Literature DB >> 17565454

A prediction model for bacterial etiology in acute exacerbations of COPD.

H Lode1, M Allewelt, S Balk, A De Roux, H Mauch, M Niederman, M Schmidt-Ioanas.   

Abstract

OBJECTIVES: Bacteria play a leading role in acute exacerbations of chronic obstructive pulmonary disease (COPD), but we lack predictors of bacterial etiology. We developed a prediction model for infection with gram-negative enteric bacteria (GNEB) and Pseudomonas aeruginosa.
METHODS: Clinical presentation, sputum characteristics, microbial sputum patterns, lung function and previous and concomitant medication were prospectively recorded in patients with moderate to severe exacerbation of COPD. Risk factors for a specific bacterial etiology were calculated and a prediction model developed.
RESULTS: A total of 193 patients with acute exacerbation were included. In 121 (62.6%) of them a microbial etiology could be identified, most frequently Haemophilus influenzae (32 strains), Streptococcus pneumoniae (22 strains) and P. aeruginosa (12 strains). Multivariate analysis identified severe airflow obstruction and use of systemic steroids as predictors for exacerbation due to gram-negative enteric bacilli and P. aeruginosa. A prediction model including FEV1 < 35% of predicted value, systemic steroid use and prior antibiotic therapy within preceeding 3 months had a negative predictive of 89%, being a helpful tool in excluding patients at risk of exacerbation due to gram-negative enteric bacilli and P. aeruginosa when all criteria are absent.
CONCLUSION: A simple prediction model based on three factors may identify COPD patients at low risk for exacerbations with gram-negative enteric bacilli and P. aeruginosa. Bacterial Etiology in COPD Exacerbations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565454     DOI: 10.1007/s15010-007-6078-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

3.  A predictive model for the development of chronic obstructive pulmonary disease.

Authors:  Y I Guo; Yanrong Qian; Y I Gong; Chunming Pan; Guochao Shi; Huanying Wan
Journal:  Biomed Rep       Date:  2015-08-05

4.  N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.

Authors:  Tiemei Zhao; Youning Liu
Journal:  BMC Microbiol       Date:  2010-05-12       Impact factor: 3.605

5.  Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study.

Authors:  M Montero; M Domínguez; M Orozco-Levi; M Salvadó; H Knobel
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

6.  Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease.

Authors:  David M Jacobs; Heather M Ochs-Balcom; Jiwei Zhao; Timothy F Murphy; Sanjay Sethi
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 7.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

8.  Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection.

Authors:  Fabienne Gally; Hong Wei Chu; Russell P Bowler
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

Review 9.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31

10.  Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease.

Authors:  Huaying Wang; Xiao Gu; Yuesong Weng; Tao Xu; Zhongming Fu; Weidong Peng; Wanjun Yu
Journal:  BMC Pulm Med       Date:  2015-08-19       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.